469 related articles for article (PubMed ID: 8832488)
1. In-vitro and ex-vivo inhibition of blood platelet aggregation by naftazone.
Durand P; Bloy C; Peltier-Pujol F; Blache D
J Pharm Pharmacol; 1996 Jun; 48(6):566-72. PubMed ID: 8832488
[TBL] [Abstract][Full Text] [Related]
2. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
[TBL] [Abstract][Full Text] [Related]
3. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
Huzoor-Akbar ; Anwer K
Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Weber AA; Reimann S; Schrör K
Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
[TBL] [Abstract][Full Text] [Related]
5. Localization of fibrinogen during ADP- or thrombin-induced aggregation of washed rabbit platelets.
Suzuki H; Kinlough-Rathbone RL; Packham MA; Mustard JF; Tanoue K; Yamazaki H
J Histochem Cytochem; 1990 Jun; 38(6):869-74. PubMed ID: 2335742
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
7. Unexpected effects of aurin tricarboxylic acid on human platelets.
Kinlough-Rathbone RL; Packham MA
Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
[TBL] [Abstract][Full Text] [Related]
8. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat.
Clowes AW; Karnovsky MJ
Lab Invest; 1977 Apr; 36(4):452-64. PubMed ID: 846193
[TBL] [Abstract][Full Text] [Related]
9. Exogenous GTP increases cyclic GMP and inhibits thrombin-induced aggregation of washed human platelets: comparison with ATP, adenosine and guanosine.
Vuorinen P; Laustiola KE
Pharmacol Toxicol; 1992 Oct; 71(4):289-93. PubMed ID: 1333596
[TBL] [Abstract][Full Text] [Related]
10. Ticlopidine facilitates the deaggregation of human platelets aggregated by thrombin.
Cattaneo M; Akkawat B; Kinlough-Rathbone RL; Packham MA; Cimminiello C; Mannucci PM
Thromb Haemost; 1994 Jan; 71(1):91-4. PubMed ID: 8165651
[TBL] [Abstract][Full Text] [Related]
11. Diurnal variation in melatonin effect on adenosine triphosphate and serotonin release by human platelets.
Del Zar MM; Martinuzzo M; Cardinali DP; Carreras LO; Vacas MI
Acta Endocrinol (Copenh); 1990 Oct; 123(4):453-8. PubMed ID: 2239090
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of rat platelet aggregation by mycalolide-B, a novel inhibitor of actin polymerization with a different mechanism of action from cytochalasin-D.
Sugidachi A; Ogawa T; Asai F; Saito S; Ozaki H; Fusetani N; Karaki H; Koike H
Thromb Haemost; 1998 Mar; 79(3):614-9. PubMed ID: 9531051
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by sodium nitroprusside or PGE1 of tyrosine phosphorylation induced in platelets by thrombin or ADP.
Oda A; Druker BJ; Smith M; Salzman EW
Am J Physiol; 1992 Mar; 262(3 Pt 1):C701-7. PubMed ID: 1372480
[TBL] [Abstract][Full Text] [Related]
14. Antihistaminic drug bromadryl and stimulated platelet aggregation.
Nosál R; Jancinová V; Petríková M
Agents Actions; 1994 Jun; 41 Spec No():C104-5. PubMed ID: 7976789
[TBL] [Abstract][Full Text] [Related]
15. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.
Gachet C; Cazenave JP; Ohlmann P; Bouloux C; Defreyn G; Driot F; Maffrand JP
Biochem Pharmacol; 1990 Dec; 40(12):2683-7. PubMed ID: 2175608
[TBL] [Abstract][Full Text] [Related]
16. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
17. Effect of low doses of ethanol on platelet function in long-life abstainers and moderate-wine drinkers.
Miceli M; Alberti L; Bennardini F; Di Simplicio P; Seghieri G; Rao GH; Franconi F
Life Sci; 2003 Aug; 73(12):1557-66. PubMed ID: 12865095
[TBL] [Abstract][Full Text] [Related]
18. Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
Tohti I; Tursun M; Umar A; Turdi S; Imin H; Moore N
Thromb Res; 2006; 118(6):733-9. PubMed ID: 16469363
[TBL] [Abstract][Full Text] [Related]
19. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man.
Gachet C; Stierlé A; Cazenave JP; Ohlmann P; Lanza F; Bouloux C; Maffrand JP
Biochem Pharmacol; 1990 Jul; 40(2):229-38. PubMed ID: 2375765
[TBL] [Abstract][Full Text] [Related]
20. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]